Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Carlos Gil, Ferreira"'
Autor:
Mariano Zalis, Gilson Gabriel Viana Veloso, Pedro Nazareth Aguiar Jr., Nathalia Gimenes, Marina Xavier Reis, Silvio Matsas, Carlos Gil Ferreira
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Fundamentally precision oncology illustrates the path in which molecular profiling of tumors can illuminate their biological behavior, diversity, and likely outcomes by identifying distinct genetic mutations, protein levels, and other biomarkers that
Externí odkaz:
https://doaj.org/article/6ccfcb1cf470465abaf8918611325314
Autor:
Pedro Aguiar Junior, Pedro De-Marchi, Rafael Paes, Isabella Favato, Gabriela Monte, Tatiane Montella, Filipe Visani, Nathalia Afonso, Izabella Negreiros, Rodrigo Dienstmann, Carlos Gil Ferreira
Publikováno v:
Brazilian Journal of Oncology, Vol 19 (2023)
INTRODUCTION: Immunotherapy led to increased survival in advanced non-small cell lung cancer; however, it has also increased treatment costs. In this study, real-world data was used to evaluate the average cost of treatment of patients with lung canc
Externí odkaz:
https://doaj.org/article/d58a627f4c00416da5abac6aa5924ee9
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/f877df3f574d48bfb56ab3e342332fd8
Autor:
Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa e Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, César Serrano
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEMutations of the KIT gene are the molecular hallmark of most GI stromal tumors (GISTs). Imatinib has revolutionized GIST treatment. Adjuvant imatinib for 3 years is the standard of care for high-risk resected GIST. However, the GIST molecular
Externí odkaz:
https://doaj.org/article/73f84fe9ba8a4e9b9b0f15018479bb0c
Autor:
Tatiane Montella, Mariano Zalis, Mauro Zukin, Vladmir Claudio Cordeiro de Lima, Clarissa Baldotto, Pedro De Marchi, Paulo Salles, Clarissa Mathias, Carlos Barrios, Carolina Kawamura, Aknar Calabrich, Luiz Henrique Araújo, Gilberto Castro, Carolina Bustamante, André Santa Maria, Marcelo Reis, Carlos Gil Ferreira
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThere is a paucity of consistent data concerning genetic mutations in Brazilian patients with lung cancer. The aim of this study was to retrospectively analyze epidermal growth factor receptor (EGFR) mutations detected in a real-world scenario
Externí odkaz:
https://doaj.org/article/f9cd238c745a47a8a501fcfba1fb18c5
Autor:
Bruno L. Ferrari, Carlos Gil Ferreira, Márcia Menezes, Pedro De Marchi, Jorge Canedo, Andréia Cristina de Melo, Alexandre A. Jácome, Tomás Reinert, Rafael Duarte Paes, Bárbara Sodré, Carlos H. Barrios, Rodrigo Dienstmann
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 46-55 (2021)
PURPOSEThe COVID-19 pandemic remains a public health emergency of global concern. Determinants of mortality in the general population are now clear, but specific data on patients with cancer remain limited, particularly in Latin America.MATERIALS AND
Externí odkaz:
https://doaj.org/article/10ad72b4b6d04a04aabd7a3b9deccbf0
Autor:
Carlos Gil Ferreira, Marcia Datz Abadi, Paula de Mendonça Batista, Fernando Brandão Serra, Rodrigo Buzzatti Peixoto, Lucas Miyake Okumura, Erica Regina Cerqueira
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1454-1461 (2021)
PURPOSENon–small-cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for 80%-90% of the cases. In Brazil, between 2018 and 2019, lung cancer was ranked as the second most frequent cancer among men and the fourth among women
Externí odkaz:
https://doaj.org/article/3a9eed2332a44d41a34e90d732980882
Autor:
Lilian Dantonino Faroni, Arthur Accioly Rosa, Veronica Aran, Renan Serrano Ramos, Carlos Gil Ferreira
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 726-733 (2021)
PURPOSELung cancer is a global health problem, with more than 220,000 new cases and 150,000 deaths per year in the United States. Likewise, in Brazil, lung cancer is the most lethal cancer with 30,200 new cases expected in 2020. Regarding treatment t
Externí odkaz:
https://doaj.org/article/2b61fd5704754d3c9cebf3d9f30c9727
Autor:
Flavia A. Duarte, Carlos Gil Ferreira, Rodrigo Dienstmann, Bruno L. Ferrari, Matheus Costa E Silva, Pedro Nazareth A. Junior, Paulo Guilherme de O. Salles, Paulo Henrique C. Diniz
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Background Precision oncology has a prominent role in nonsquamous non-small cell lung cancer (nsNSCLC) treatment progress; however, its access in a real-world scenario might be limited.Objective To investigate the time spent in nsNSCLC molecular prof
Externí odkaz:
https://doaj.org/article/67a5982c050a454aa680876de22bc6ae
Real-World Evidence of Health Outcomes Related to Lung Stereotactic Body Radiation Therapy in Brazil
Autor:
Lilian Faroni, Carlos Gil Ferreira, Fabio Moraes, Clarissa Baldotto, Mauro Zukin, Veronica Aran, Luiz Henrique Araujo
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEStereotactic body radiation therapy (SBRT) is an effective option for patients with both early-stage and oligometastatic non–small-cell lung cancer (NSCLC). However, data from Latin America are limited. Therefore, the aim of this study was t
Externí odkaz:
https://doaj.org/article/adf42e88a5a54c68bf1e208ff701bdef